Related Experiment Video
Updated: May 18, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Childhood cancer: incidence and early deaths in Argentina, 2000-2008
Florencia Moreno1, Dora Loria, Graciela Abriata
1Argentinean Oncopediatric Registry, National Cancer Institute, Buenos Aires City, Argentina. roha@roha.org.ar
Insights
Childhood cancer incidence in Argentina is lower than in North America and Western Europe, with no increase observed. Early deaths suggest challenges in cancer care organization.
Area of Science:
- Pediatric Oncology
- Epidemiology
- Public Health
Background:
- Limited data exists on childhood cancer epidemiology in Latin America.
- The Argentinean Oncopaediatric Registry (ROHA) has collected data since 2000.
- This study analyzes ROHA data from 2000-2008.
Purpose of the Study:
- To describe the epidemiology of childhood cancer in Argentina.
- To establish incidence rates and common cancer types.
- To identify areas for improving childhood cancer care.
Main Methods:
- Utilized data from the Argentinean Oncopaediatric Registry (ROHA).
- Included cases from paediatric units and population-based cancer registries.
- Classified cancers using the International Classification of Childhood Cancer.
Main Results:
- 11,447 childhood cancer cases (ages 0-14) were reported.
- The standardized incidence rate was 128.5 per million; leukaemias (37%), CNS tumors (18%), and lymphomas (13%) were most common.
- Leukemia incidence peaked around age 3; 80% of patients used public hospitals, and 35% migrated for treatment.
Conclusions:
- Childhood cancer incidence in Argentina is lower than in North America/Western Europe, mainly due to CNS and other solid tumors.
- No increasing trend in childhood cancer incidence was observed.
- High early mortality rates indicate suboptimal organization of childhood cancer care.
Introduction:
Knowledge on the epidemiology of childhood cancer in Latin America is limited. The Argentinean Oncopaediatric Registry (ROHA) has been active since 2000. Data for 2000-2008 are described in the present work.
Materials And Methods:
ROHA is fed from a network of paediatric units and population-based cancer registries. Cases are coded by the International Classification of Childhood Cancer.
Results:
A total of 11447 children aged 0-14 diagnosed with cancer were reported. Histologically verified cases and cases identified only through death certificates were respectively 91% and 6%. The annual age of standardised incidence rate of all cancers was 128.5 per million. Proportions of leukaemia's, lymphoma's and Central Nervous System tumours were 37%, 13% and 18%. The distribution of rates of acute lymphatic leukaemia by the year of age showed a peak around age 3. Eighty percent of the patients are treated in public hospital and around 35% migrate for some of the treatment. Deaths within a month of diagnosis were 5% in 2000 and 3% in 2008.
Conclusions:
Childhood cancer incidence in Argentina is somewhat lower than in North American and in Western European countries: the deficit is mainly due to tumours of the Central Nervous system and other solid tumours. Childhood cancer incidence did not show any tendency to increase. The possible excess of Hodgkin lymphoma in the Northeast region requires additional studies. Early deaths after diagnosis indicate an unsatisfactory state of the overall organisation of childhood cancer care. Data from ROHA are used for decision making at local and national levels.
Related Concept Videos
Cancer Survival Analysis
Cancer Prevention
Some...
Cancer Prevention
Some...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
